{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Tao Synergies Inc."},"Symbol":{"label":"Symbol","value":"TAOX"},"Address":{"label":"Address","value":"1185 AVENUE OF THE AMERICAS,3RD FLOOR, NEW YORK, New York, 10036, United States"},"Phone":{"label":"Phone","value":"800-811-5591"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"TAO Synergies Inc. is the first pure-play public company focused on the convergence between cryptocurrency and artificial intelligence (AI). The Company's differentiated cryptocurrency treasury strategy is centered exclusively on the acquisition of TAO, the native cryptocurrency of Bittensor, a decentralized blockchain network for machine learning and AI. TAO Synergies Inc. seeks to stake TAO for revenue generation and capital appreciation, a strategy that underscores its mission to create significant value for shareholders."},"CompanyUrl":{"label":"Company Url","value":"https://www.synaptogen.com"}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}